Although the metabolism of pregnenolone (3,Bhydroxypregn-5-en-20-one) has been studied both in vitro and in vivo, there have been only two reports of the formation of A16-steroids from this substrate. Burstein & Dorfman (1962) found that, after [4-14C] cholesterol and [7ax-3H]pregnenolone had been administered to a woman with a virilizing adrenal adenoma, the An-a* subsequently isolated from her urine contained both isotopes. More recently, Ahmad & Gower (1966) showed that small quantities of two other A16-steroids, closely related to An-ae, namely 5fl-androst-16-en-3a-ol and androsta-4,16-dien-3-one, were formed in the metabolism of [4-14C] pregnenolone in rat testis tissue. Other compounds, including DHA (Gower, 1966) , DHA acetate (Gower, 1963) and testosterone (Stylianou, Forchielli & Dorfman, 1961a; Stylianou, Forchielli, Tummillo & Dorfman, 1961b) , can also serve as substrates, but the yields of the A16-steroids are fairly low. Since two of these compounds, namely An-ac and its 3,-epimer An-,B, were originally isolated from pig testes (Prelog & Ruzicka, 1944) , it was considered possible that tissue from this species might have a greater capacity for transforming pregnenolone into A16-compounds. The present work, part of which has been briefly reported (Gower & Ahmad, 1966b) was therefore undertaken to investigate this possibility, both boar testis and adrenocortical tissue being employed. In addition, a number of metabolites of pregnenolone more polar than the A16-androstenols have been isolated, * Abbreviations: An-oc, 5a-androst-16-en-3tx-ol; An-P,I
5oc-androst-16-en-3fi-ol; DHA, dehydroepiandrosterone. including progesterone, androstenedione (androst-4-ene-3,17-dione), testosterone and, from testis only, a small quantity of DEA.
On the basis of these results, a new pathway is suggested for the biosynthesis of A16-steroids from pregnenolone, with progesterone as a possible 5, 3, 5(10) , 16-tetraen-3-ol. An-ae was prepared by Brooksbank & Haslewood (1961) . Sfl-Androst-16-en-3a-ol, androsta-5,16-dien-3f,-ol, 3, 5(10), were generously supplied by Dr C. L. Hewett (Organon Laboratories Ltd., Lanarkshire, Scotland). Androsta-4,16-dien-3-one was prepared by oxidation of androsta-5,16-dien-3fl-ol (Brooksbank& Gower, 1964 Column chromatography. The crude extracts were chromatographed on alumina (5g.) and benzene-light petroleum (1:1, v/v) was used to elute A16-steroids, essentially as described by Gower & Haslewood (1961) . For the elution of more polar steroids, however, benzene-ethanol mixtures were used (Table 1) (Ahmad & Gower, 1966 ).
Paper and thin-layer chromatography. The Bush (1952) system A was used for the initial separation of the metabolites more polar than A16-steroids.
Thin-layer chromatography was carried out on Kieselgel G that contained fluorescein. The two systems used for the separation of Al6-steroids (Gower, 1964) were toluene-ethyl acetate (9:1, v/v) and benzene-ether (9:1, v/v). Acetates of these compounds were run in toluene-ethyl acetate (19:1, v/v). Benzene-acetone (4:1, v/v) was mainly employed in the chromatography of steroids more polar than the A1s.
steroids.
Detection of8teroids. The A16-steroids and A5-3fl-hydroxy steroids were detected by spraying with a saturated solution of iodine in light petroleum (b.p. 60-80'). The presence of A4-3-oxo steroids was revealed with u.v. light (254m,u).
Radioautography. This was performed with Kodirex X-ray film (Kodak Ltd., London, W.C. 1) after thin-layer chromatography.
Gas-liquid chromatography. Gas Determination of radioactivity. A Packard Tri-Carb liquid-scintillation spectrometer (model 3003) was used for radioactive counting. Fractions were dissolved in xylene (8ml.) containing 2,5-diphenyloxazole (0-3%, w/v). The counting efficiency for 14C was 75% with background about 18counts/min.
RESULTS
Identification of A16-steroid8. Alumina column fractionsI-III (Table 1) were submitted to thin-layer chromatography with toluene-ethyl acetate (9:1, v/v) together with the mixture of authentic A16- steroids. After development, the plates were dried and then developed again in the same direction with the same solvent mixture. This process was repeated once more as described by Gower (1964) . Radioautography revealed three radioactive spots, which had the mobility of androsta-4,16-dien-3-one, An-oc and An-,B in both the adrenal and testicular extracts, although the amount of these steroids seemed to be greater in the testicular extract. The zones containing these compounds were eluted with three 2ml. volumes of methanol as described by Gower (1966) The -identity of androsta-4,16-dien-3-one was proved by preparing its 2,4-dinitrophenylhydrazone as described by Stylianou et al. (1961b) . This derivative was subjected to thin-layer chromatography with carbon tetrachloride-ethanol (124:1, v/v) (Ahmad & Gower, 1966) and the radioactivity coincided with the orange-red zone of the dinitrophenylhydrazone.
It was possible, however, to carry out a more detailed study to confirm the formation of An-a, and the mixture was separated on an alumina colunm with benzene-light petroleum (80-100O) (1:1, v/v) as described above except that fractions (5ml.) were collected until both steroids were completely eluted. In each fraction the weight of steroid was determined by gas-liquid chromatography and the radioactivity measured. There was coincidence ofradioactivity and mass peaks for both compounds (Fig. 1) . Similarly, An-a was chromatographed on a separate alumina column and radioactivity and mass peaks were again plotted (Fig. 2) . Although there was coincidence of radioactivity and mass peaks, there was some tailing of radioactivity, which suggested the presence of a labelled contaminant only partially resolved from An-ac. For final identification, the tubes that contained androsta-4,16-dien-3-one were pooled and the dinitrophenylhydrazone was prepared. Radioautography indicated a radioactive spot that coincided with the coloured zone of the authentic derivative. Similarly, the tubes containing radioactivity corresponding to carrier An-ac and An-fl were pooled separately and the whole of the An-ec and a portion of the An-,B were acetylated. The acetates were subjected to thin-layer chromatography with toluene-ethyl acetate (19:1, v/v) and the radioactivity associated with the prepared derivatives was eluted. This was subjected to hydrolysis (Bush & Willoughby, 1957) and, after rechromatography in the above system, followed by radioautography, showed radioactive spots having the same mobilities as pure An-ac and An-fl. To the remainder of the pooled An-fl obtained from alumina chromatography was added authentic An-fl (15-20 mg.) and recrystallization to constant specific activity was carried out ( Table 2) .
The results reported in the preliminary account of these experiments (Gower & Ahmad, 1966b) were in terms of the total wet weight of adrenal and testis tissue. Table 3 summarizes the percentage yield of metabolites corrected for analytical losses and expressed per g. wet wt. of tissues.
Identifcation of steroids more polar than A16-8teroids. Column fractions IV and V (Table 1) were chromatographed on paper with pure steroids used as markers in the Bush (1952) Table 1 ( Table 2 ). This steroid seemed to have formed in relatively larger quantity in adrenal than testis tissue. The DHA zone was chromatographed with benzene-acetone (4:1, v/v). There was a small amount of radioactivity associated with the DHA spot formed in the testis incubation, but no radioactivity could be detected in the adrenal tissue incubation. The radioactive zone corresponding to DHA was eluted and acetylated with acetic anhydride and pyridine overnight at room temperature. After chromatography of the product with benzene-ether (4:1, v/v), the spot corresponding to DHA acetate was eluted and counted. No further purification could be carried out owing to the small amount of radioactivity present. After paper chromatography of column fraction V, only two radioactive zones could be detected, one corresponding in mobility to testosterone and the other to pregnenolone. The testosterone zone was eluted and subjected to thin-layer chromatography with chloroform-methanol (49:1, v/v) . A radioactive spot corresponding to 17a-hydroxyprogesterone was found only in adrenal tissue, but further purification failed to confirm its identity. Testosterone, which seemed to be present in both incubation experiments, was subjected to thinlayer chromatography with benzene-ethyl acetate (1:1, v/v). Radioautography again indicated radioactive spots overlapping with the spots produced by carrier testosterone under u.v. light. Further confirmation of the identity of testosterone was provided by crystallization to constant specific activity ( Table 2 ). The pregnenolone zone was purified by thin-layer chromatography (Scheme 1).
The radioactivity in column fraction VI represented 3-5% of the total activity applied to the columns, but no attempts were made to purify and identify the metabolites that might have been present. DISCUSSION
The suggestion of Neher & Wettstein (1960) (Acevedo, Axelrod, Ishikawa & Takaki, 1961) , ox (Kahnt, Neher, Schmid & Wettstein, 1961) , rat (Ahmad & Gower, 1966) and mouse (Grosso & Ungar, 1964) . The second pathway, involving the A5-3fl-hydroxy steroids, 17o-hydroxypregnenolone and DHA, has been elucidated by, e.g., Goldstein, Gut & Dorfman (1960) , Eik-Nes & Hall (1962) , EikNes & Kekre (1963) and Hall, Sozer & Eik-Nes (1964) . In kinetic experiments with rat-testis homogenate, Slaunwhite & Burgett (1965) showed that androstenedione and testosterone were formed independently, the former via the A4 pathway and the latter by the A5 pathway. The step between 17o-hydroxypregnenolone and DHA was found to be rate-limiting. In some preparations, e.g. in rattestis microsomes (Shikita, Kakizaki & Tamaoki, 1964) , the L4 pathway occurs preferentially, little or no A5-3f-hydroxy steroids being formed. In the present experiments with boar adrenal and testis tissue, a fixed 4 hr. incubation time was used and a direct comparison of the two pathways is therefore difficult to make. The isolation of progesterone, androstenedione and testosterone at this time (Table 3) , but little or no labelled A5-3fl-hydroxy steroids, however, suggests that the A'4 pathway may be occurring preferentially.
Bio8ynthe8i8 of A16-8teroid8. The experiments of Stylianou et al. (1961a,b) , in which testosterone was transformed into small quantities of androsta-4,16-dien-3-one and An-f,, led these workers to suggest that the elements of water were eliminated between C-16 and the 17-hydroxyl group of testosterone, resulting in the formation of the A4"16-ketone. Reduction in ring A could then presumably lead to one or more of the A16-androsten-3-ols. Dorfman (1961) subsequently postulated An-ac as the specific metabolite of testosterone, but experiments in vivo performed in a number of Laboratories failed to confirm either this conversion or that of DHA into An-a (Bulbrook, Thomas & Brooksbank, 1963; Ahmad & Morse, 1965; Cleveland & Savard, 1964) . In accord with these studies in vivo, no A16-compounds were found with testosterone as substrate with boar adrenal and testis tissue (Gower & Ahmad, 1966a) , and only very small yields with DHA acetate with ox adrenal (Gower, 1963) and DHA with rat testis (Gower, 1966) . The possibility that the 17,8-acetate of testosterone, as opposed to testosterone itself, might give greater yields of A16-steroids has been pursued in preliminary experiments in this Laboratory with boar testis tVssue because the chemical dehydration of compounds such as testosterone toluene-p-sulphonate is known to result in androsta-4,16-dien-3-one (Henbest & Jackson, 1962) . These experiments, however, have failed to confirm testosterone acetate as a precursor, although ofcourse the ester may have been hydrolysed by esterase activity before any significant conversion into A16-steroids could occur.
The present results ( The results presented in this paper are in accord with those of Burstein & Dorfman (1962) , who showed that both cholesterol and pregnenolone gave rise to An-cain vivo. They are also in agreement with the studies of Brooksbank (1962) and of Cleveland & Savard (1964) , in which the administration of adrenocorticotrophic hormone to normal human subjects increased their urinary An-a excretion. Adrenocorticotrophic hormone is now known to act specifically at the steps in steroidogenesis between cholesterol and pregnenolone (Karaboyas & Koritz, 1965) and would therefore be expected to increase the formation of A16-steroids if cholesterol and pregnenolone were precursors.
